Gemcitabine 38 mg/mL (Gemcitabine INJECTION, SOLUTION) 38 mg/mL

Gemcitabine 38 mg/mL is an intravenous solution used for various medical treatments. This injection, manufactured by Sagent Pharmaceuticals, is a crucial component in certain therapeutic regimens.

Strength

38 mg/mL

Pack Size

1 VIAL in 1 CARTON (25021-239-05) / 5.26 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Gemcitabine 38 mg/mL is primarily used in intravenous therapy. It is often incorporated into treatment plans for specific medical conditions, where it plays a role in managing or alleviating symptoms. The solution is designed to be administered by healthcare professionals in controlled settings.

Side Effects

Common effects of Gemcitabine 38 mg/mL may include temporary discomfort at the injection site or general fatigue. Some individuals might experience mild to moderate reactions, which typically subside over time. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Precautions & Warnings

Gemcitabine 38 mg/mL should be handled with care, following strict medical guidelines. It is essential to ensure proper storage and administration to maintain its efficacy and safety. Patients should discuss their medical history and any current medications with their healthcare provider before starting treatment.

Avoid Interactions

Gemcitabine 38 mg/mL may interact with certain medications or substances, including other intravenous drugs. It is important to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances should be discussed with a healthcare professional to ensure safe usage.

Frequently Asked Questions

Gemcitabine 38 mg/mL is used in intravenous therapy for specific medical conditions. It is often part of a treatment plan designed by healthcare professionals.

Gemcitabine 38 mg/mL is administered intravenously by healthcare professionals in a controlled medical setting.

Common effects may include temporary discomfort at the injection site or general fatigue. Some individuals might experience mild to moderate reactions.

Yes, it should be handled with care, following strict medical guidelines. Proper storage and administration are crucial for maintaining its efficacy and safety.

Yes, it may interact with certain medications or substances. It is important to inform healthcare providers about all current medications to avoid potential interactions.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.